A Phase 1b Study of Vadastuximab Talirine in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Erba, HP; Levy, MY; Vasu, S; Stein, AS; Fathi, AT; Maris, MB; Advani, A; Faderl, S; Smith, SE; Wood, BL; Walter, RB; Yang, J; Donnellan, WB; Feldman, EJ; Voellinger, JL; Ravandi, F

Published Date

  • December 2, 2016

Published In

Volume / Issue

  • 128 / 22

Published By

Pages

  • 7

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 3, 2016

Conference End Date

  • December 6, 2016